Editorial Board
Anna Jezierski
National Research Council Canada, Human Health Therapeutics Research Area, Ottawa · Canada
Editorial leadership for Journal of Body Fluids
Research interests
- Pcr
- Cell Culture
- Gene Expression
- Flow Cytometry
- Immunohistochemistry
- Molecular Cell Biology
- Immunofluorescence
- Molecular Genetics
- Cell Signaling
- Protein Expression
- Rna Extraction
- Cell Line Culture
- Primary Cell Culture
- Biomedical Science
- Immunofluorescence Staining
- In Vitro Cell Culture
- Cellular Biology
- Human Cell Culture
- Medical Biotechnology
- Biomedicine
Biography
Publications:
- A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.
- Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system.
- Human Amniotic Fluid Cells Form Functional Gap Junctions with Cortical Cells.
- A Unique Interplay Between Rap1 and E‐Cadherin in the Endocytic Pathway Regulates Self‐Renewal of Human Embryonic Stem Cells.
- Epigenetic modifications ofSOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation.
- Novel RBPJ Transcripts Identified in Human Amniotic Fluid Cells.
- Involvement of NOS3 in RA-Induced neural differentiation of human NT2/D1 cells.
- Neuroprotective Effects of GDNF-expressing Human Amniotic Fluid Cells.
Selected publications
- Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22 2024
- Single-Step 3D Bioprinting of Alginate–Collagen Type I Hydrogel Fiber Rings to Promote Angiogenic Network Formation 2024
- Angiogenesis driven extracellular matrix remodeling of 3D bioprinted vascular networks 2023
- Improved Cryopreservation of Human Induced Pluripotent Stem Cell (iPSC) and iPSC-derived Neurons Using Ice-Recrystallization Inhibitors 2023
- Mouse embryonic stem cell-derived blood–brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis 2023
- Application of blood brain barrier models in preclinical assessment of glioblastoma- targeting CART based immunotherapies 2022
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBF for your work?
This journal is guided by Anna Jezierski (National Research Council Canada, Human Health Therapeutics Research Area, Ottawa) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.